Runben Biotechnology Co., Ltd.

¥17.41As of Sun 8 Nov 2026, 12:00 UTC
SSE:603193Consumer Staples
Country China
PE (Fwd) •••
TSR 3Y CAGR (1.60%)
Div yield 3.10%
ROE 15.58%
Household & Personal Products
Beta (5Y) 0.35
PE TTM 20.23
TSR TTM (32.70%)
Mkt cap ¥7.044B
ROIC 38.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
25.63%
37.38%
Buy 6|8|5|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.20
0.21
0.23
0.23
20.09%
33.63%
36.64%
24.26%
Revenue¥M
361.1
354.6
349.2
344.5
7.91%
2.77%
(0.44%)
(6.73%)
Peers (US$1.056B)
Cap (US$)
PE
1.202B
12.09x
943.6M
30.61x
978.1M
19.27x
Capital
TTM
5Y
10Y
Leveragex
0.620
0.058
0.063
EBIT/Intx
0.304
0.698
0.732
Own earn%
(255.60)
(125.25)
(122.49)
Sh yield%
22.51
47.95
45.95
Owners
Insiders/Inst%
4.95
74.88
Short interest%
2.02
SBC / revenue%
3.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
4–9
$1 testx
—
Incr. ROIC%
9